Quest Diagnostics Incorporated · NYSE:DGX
Delaney Mark E sold 1,600 Quest Diagnostics Incorporated shares (Form 4)
Traded Jul 28, 2026 · Filed Jul 29, 2026
On Jul 28, 2026, Delaney Mark E (SVP & Chief Commercial Officer) sold 1,600 Quest Diagnostics Incorporated shares at US$235.18 for US$376K under a trading plan, leaving 10,335 shares. Filed Jul 29, 2026 (Form 4).
- Sold
- 1,600 shares
- Price
- US$235.18
- Value
- US$376K
- Holding after
- 10,335 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- SVP & Chief Commercial Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Jul 28, 2026 | Common Stock | Sale | 1,600 | US$235.18 | 10,335 | Direct |
Source
Related
- Quest Diagnostics Incorporated
- Delaney Mark E
- Quest Diagnostics Incorporated shareholders
- Form 4 · Delaney Mark E · Jul 27, 2026
- Form 4 · Delaney Mark E · Apr 24, 2026
- Form 4 · Davis J. E. · Sep 3, 2026
- Form 4 · Prevoznik Michael E · Aug 31, 2026
- Schedule 13G/A · T. Rowe Price Associates Inc · Aug 14, 2026
- Form 4 · Kuppusamy Karthik · Jul 27, 2026
- Form 4 · Carter Robert B · Jul 27, 2026